The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Phase I study of peptide receptor radionuclide therapy with [111In-DTPA0]octreotide: The rotterdam experience
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Reporting results of cancer treatment
Miller, A. B., Hoogstraten, B., Staquet, M., & Winkler, A. (1981) · Cancer · doi:10.1002/1097-0142(19810101)47:1<207::aid-cncr2820470134>3.0.co;2-6 · Cited by 7,793
Tolerance of normal tissue to therapeutic irradiation
Emami, B., Lyman, J., Brown, A., Cola, L., Goitein, M., Munzenrider, J. E., Shank, B., Solin, L. J., & Wesson, M. (1991) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/0360-3016(91)90171-y · Cited by 4,488
Krenning, E. P., Kwekkeboom, D. J., Bakker, W. H., Breeman, W. A. P., Kooij, P. P. M., Oei, H. Y., van Hagen, M., Postema, P. T. E., de Jong, M., Reubi, J. C., et al. (1993) · European Journal of Nuclear Medicine · doi:10.1007/bf00181765 · Cited by 1,564
Self-citationMoertel, C. G., Kvols, L. K., O'Connell, M. J., & Rubin, J. (1991) · Cancer · doi:10.1002/1097-0142(19910715)68:2<227::aid-cncr2820680202>3.0.co;2-i · Cited by 840
Brenner and Rector's The Kidney
Bazilinski, N. G. (2000) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.284.1.100 · Cited by 577
Brenner and Rector's the Kidney
Brenner, B. M. (2003) · Medical Entomology and Zoology · Cited by 561
[177Lu-DOTA0,Tyr3]octreotate: comparison with [111In-DTPA0]octreotide in patients
Kwekkeboom, D. J., Bakker, W. H., Kooij, P. P., Konijnenberg, M. W., Srinivasan, A., Erion, J. L., Schmidt, M. A., Bugaj, J. L., de Jong, M., & Krenning, E. P. (2001) · European Journal of Nuclear Medicine · doi:10.1007/s002590100574 · Cited by 471
Self-citationKrenning, E. P., Bakker, W., Kooij, P. P. M., Breeman, W. A., Oei, H. Y., de Jong, M., Reubi, J. C., Visser, T. J., Bruns, C., & Kwekkeboom, D. J. (1992) · PubMed · Cited by 420
Self-citationYttrium-90 DOTATOC: first clinical results
Otte, A., Herrmann, R., Heppeler, A., Behe, M., Jermann, E., Powell, P., Maecke, H. R., & Muller, J. (1999) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s002590050476 · Cited by 420
Waldherr, C., Pless, M., Maecke, H. R., Haldemann, A., & Mueller-Brand, J. (2001) · Annals of Oncology · doi:10.1023/a:1011160913619 · Cited by 396
Serum Inhibin B as a Marker of Spermatogenesis
Pierik, F. H., Vreeburg, J. T. M., Stijnen, T., de Jong, F. H., & Weber, R. F. A. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.83.9.3110 · Cited by 353
Yttrium-90-labelled somatostatin-analogue for cancer treatment
Otte, A., Mueller-Brand, J., Dellas, S., Nitzsche, E., Herrmann, R., & Maecke, H. (1998) · The Lancet · doi:10.1016/s0140-6736(05)78355-0 · Cited by 335
Bakker, W. H., Albert, R., Bruns, C., Breeman, W. A. P., Hofland, L. J., Marbach, P., Pless, J., Pralet, D., Stolz, B., Koper, J. W., et al. (1991) · Life Sciences · doi:10.1016/0024-3205(91)90052-d · Cited by 328
Self-citationKRENNING, E. P., KOOIJ, P. P. M., BAKKER, W. H., BREEMAN, W. A. P., POSTEMA, P. T. E., KWEKKEBOOM, D. J., OEI, H. Y., de JONG, M., VISSER, T. J., REIJS, A. E. M., et al. (1994) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1994.tb17300.x · Cited by 313
Self-citationThe long-term hazards of the treatment of thyroid cancer with radioiodine
Edmonds, C. J., & Smith, T. (1986) · The British Journal of Radiology · doi:10.1259/0007-1285-59-697-45 · Cited by 246
Receptor-mediated radiotherapy with 90Y-DOTA-D-Phe1-Tyr3-octreotide
Paganelli, G., Zoboli, S., Cremonesi, M., Bodei, L., Ferrari, M., Grana, C., Bartolomei, M., Orsi, F., De Cicco, C., Mäcke, H. R., et al. (2001) · European Journal of Nuclear Medicine · doi:10.1007/s002590100490 · Cited by 206
Treatment of Neuroendocrine GEP Tumours with Somatostatin Analogues
Arnold, R., Simon, B., & Wied, M. (2000) · Digestion · doi:10.1159/000051861 · Cited by 153
A Case History: NMR Studies of the Structure of a Small Protein, ω-Conotoxin MVIIA
MacLachlan, L. K., Middleton, D. A., Edwards, A. J., & Reid, D. G. (2003) · Humana Press eBooks · doi:10.1385/0-89603-309-0:337 · Cited by 150
Natural History of Neuroendocrine Enteropancreatic Tumors
Mignon, M. (2000) · Digestion · doi:10.1159/000051856 · Cited by 124
Testicular function after radioiodine therapy for thyroid carcinoma
Wichers, M., Benz, E., Palmedo, H., Biersack, H. J., Grünwald, F., & Klingmüller, D. (2000) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s002590050535 · Cited by 122
Leukaemia incidence after iodine-131 exposure
Hall, P. N. (1992) · The Lancet · doi:10.1016/0140-6736(92)92421-b · Cited by 122
State of the art and perspectives
King, M. (1993) · Machine Translation · doi:10.1007/bf00398472 · Cited by 98
Stridsberg, M., Hellman, U., Wilander, E., Lundqvist, G., Hellsing, K., & Öberg, K. (1993) · Journal of Endocrinology · doi:10.1677/joe.0.1390329 · Cited by 70
Self-citationSmith, M. C., Liu, J., Chen, T., SCHRAN, H. F., Yeh, C., Jamar, F., Valkema, R., Bakker, W. H., Kvols, L. K., Krenning, E. P., et al. (2000) · Digestion · doi:10.1159/000051858 · Cited by 69
Self-citationGuignat, L., Bidart, J., Nocera, M., Comoy, E., Schlumberger, M. J., & Baudin, É. (2001) · British Journal of Cancer · doi:10.1054/bjoc.2000.1677 · Cited by 48
Somatostatin receptors in the haematopoietic system
Oomen, S. P. M. A., Hofland, L. J., van Hagen, P., Lamberts, S., & Touw, I. P. (2000) · European Journal of Endocrinology · doi:10.1530/eje.0.143s009 · Cited by 43
Health-related Quality of Life in Patients with Endocrine Tumours of the Gastrointestinal Tract
Larsson, G., von Essén, L., & Sjödén, P. (1999) · Acta Oncologica · doi:10.1080/028418699432022 · Cited by 40
Cited by
Gastroenteropancreatic neuroendocrine tumours
Modlin, I. M., Oberg, K., Chung, D. C., Jensen, R. T., de Herder, W. W., Thakker, R. V., Caplin, M., Delle Fave, G., Kaltsas, G. A., Krenning, E. P., et al. (2008) · The Lancet Oncology · doi:10.1016/s1470-2045(07)70410-2 · Cited by 1,748
Self-citationZaknun, J. J., Bodei, L., Mueller-Brand, J., Pavel, M. E., Baum, R. P., Hörsch, D., O’Dorisio, M. S., O’Dorisiol, T. M., Howe, J. R., Cremonesi, M., et al. (2013) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-012-2330-6 · Cited by 818
The diagnosis and medical management of advanced neuroendocrine tumors.
Kaltsas, G. A., Besser, G. M., & Grossman, A. B. (2004) · Endocrine Reviews · doi:10.1210/er.2003-0014 · Cited by 674
Kwekkeboom, D. J., Teunissen, J. J., Bakker, W. H., Kooij, P. P., de Herder, W. W., Feelders, R. A., van Eijck, C. H., Esser, J.-P., Kam, B. L., & Krenning, E. P. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.08.066 · Cited by 657
Self-citationAuger electrons for cancer therapy – a review
Ku, A., Facca, V. J., Cai, Z., & Reilly, R. M. (2019) · EJNMMI Radiopharmacy and Chemistry · doi:10.1186/s41181-019-0075-2 · Cited by 643
Metadata
- Authors
- Valkema, R., de Jong, M., Bakker, W. H., Breeman, W. A. P., Kooij, P. P. M., Lugtenburg, P. J., de Jong, F. H., Christiansen, A., Kam, B. L. R., de Herder, W. W., Stridsberg, M., Lindemans, J., Ensing, G., & Krenning, E. P.
- Venue
- Seminars in Nuclear Medicine
- Publisher
- Elsevier BV
- Published
- 2002-04
- Volume
- 32
- Issue
- 2
- Pages
- 110-122
- ISSN
- 0001-2998 (ISSN-L)
- OpenAlex
- W2005907891
- Cited by
- 435
- References
- 27
- FWCI
- 17.71
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.